Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Sep;66(3):691-693.
doi: 10.1002/hep.29249. Epub 2017 Jul 20.

Toward novel immunocompetent animal models for hepatitis B virus infection

Affiliations
Editorial

Toward novel immunocompetent animal models for hepatitis B virus infection

Laurent Mailly et al. Hepatology. 2017 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no conflict of interest

Comment on

References

    1. Baumert TF, Verrier ER, Nassal M, Chung RT, Zeisel MB. Host-targeting agents for treatment of hepatitis B virus infection. Curr Opin Virol. 2015;14:41–46. - PubMed
    1. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012;1:e00049. - PMC - PubMed
    1. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology. 2014;146:1070–1083. - PubMed
    1. Allweiss L, Dandri M. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection. J Hepatol. 2016;64:S17–31. - PubMed
    1. He W, Cao Z, Mao F, Ren B, Li Y, Li D, et al. Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo. J Virol. 2016;90:8866–8874. - PMC - PubMed